Want to see HK:2591 full AI Analyst Report?
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H (2591) Financial Statements
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H Financial Overview
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H's market cap is currently $1.55B. The company's EPS TTM is $-0.74; its P/E ratio is -3.90; Guangzhou Innogen Pharmaceutical Group Co Ltd Class H has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 128.11M | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 104.43M | $ -17.28M | $ -19.65M | $ -19.08M |
| Operating Income | $ -333.90M | $ -189.36M | $ -746.84M | $ -327.45M |
| EBITDA | $ -323.92M | $ -156.89M | $ -711.42M | $ -308.37M |
| Net Income | $ -332.53M | $ -174.69M | $ -733.38M | $ -306.99M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 1.21B | $ 796.88M | $ 945.34M | $ 501.37M |
| Total Assets | $ 1.57B | $ 934.80M | $ 1.11B | $ 668.71M |
| Total Debt | $ 166.33M | $ 9.90M | $ 46.59M | $ 50.31M |
| Net Debt | $ -803.41M | $ -516.64M | $ -361.08M | $ -74.95M |
| Total Liabilities | $ 517.84M | $ 138.33M | $ 400.24M | $ 135.23M |
| Stockholders' Equity | $ 1.05B | $ 796.47M | $ 705.13M | $ 533.48M |
| Cash Flow | ||||
| Free Cash Flow | $ -317.57M | $ -166.95M | $ -176.79M | $ -226.17M |
| Operating Cash Flow | $ -295.54M | $ -162.62M | $ -164.60M | $ -197.33M |
| Investing Cash Flow | $ 22.63M | $ 275.95M | $ -157.21M | $ -77.24M |
| Financing Cash Flow | $ 722.37M | $ 254.84M | $ 351.71M | $ 9.95M |
Currency in CNY